The White House is considering former Republican Representative Michael Burgess to run the U.S. Centers for Disease Control ...
The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product ...
MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback